• Newly Approved Drug Illuminates Ovarian Cancer Tissue

  • Dec 12 2021
  • Length: 2 mins
  • Podcast

Newly Approved Drug Illuminates Ovarian Cancer Tissue By cover art

Newly Approved Drug Illuminates Ovarian Cancer Tissue

Listen for free

View show details

  • Summary

  • The U.S. Food and Drug Administration (FDA) approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove cancer. 
    Show more Show less
activate_primeday_promo_in_buybox_DT
Show more Show less

What listeners say about Newly Approved Drug Illuminates Ovarian Cancer Tissue

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available